List of works by Cyrille Touzeau

Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experience

scientific article published on 14 August 2020

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

scientific article published on 03 June 2019

Carfilzomib in combination with daratumumab in the management of relapsed multiple myeloma

scientific article published on 08 December 2020

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

scientific article published on 20 June 2022

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

scientific article

FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?

scientific article published on 28 May 2020

Fluctuating plasmacytosis in an immunocompetent woman leading a diagnosis of plasmablastic lymphoma

scientific article published on 19 March 2020

Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma

scientific article published on 29 July 2020

Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials

scientific article published on 06 September 2020

Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma

scientific article published on 19 February 2020

ImmunoPET in Multiple Myeloma-What? So What? Now What?

scientific article published on 04 June 2020

Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study

scientific article published on 01 August 2018

Multiple myeloma: from front-line to relapsed therapies

scientific article

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

scientific article

PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients

scientific article published on 18 February 2017

Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation

scientific article published on 11 March 2014

Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma

scientific article published on 17 March 2015

Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.

scientific article published on 29 April 2010

Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM.

scientific article published on 28 August 2017

Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myeloma

scientific article

Restoring Apoptosis with BH3 Mimetics in Mature B-Cell Malignancies

scientific article published on 14 March 2020

Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study

scientific article published on 30 July 2020

The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma

scientific article published on 29 August 2019

The role of SLAMF7 in multiple myeloma: impact on therapy

scientific article

Triplet combinations in relapsed/refractory myeloma: update on recent phase 3 trials

scientific article

Paulina is supported by:

About Paulina

Help